首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   730篇
  免费   29篇
  国内免费   11篇
耳鼻咽喉   11篇
儿科学   11篇
妇产科学   1篇
基础医学   58篇
口腔科学   6篇
临床医学   54篇
内科学   228篇
皮肤病学   10篇
神经病学   42篇
特种医学   128篇
外科学   70篇
综合类   17篇
一般理论   1篇
预防医学   35篇
眼科学   14篇
药学   19篇
肿瘤学   65篇
  2023年   6篇
  2022年   18篇
  2021年   29篇
  2020年   16篇
  2019年   15篇
  2018年   23篇
  2017年   19篇
  2016年   17篇
  2015年   24篇
  2014年   36篇
  2013年   37篇
  2012年   50篇
  2011年   51篇
  2010年   39篇
  2009年   30篇
  2008年   49篇
  2007年   48篇
  2006年   48篇
  2005年   53篇
  2004年   36篇
  2003年   30篇
  2002年   31篇
  2001年   6篇
  2000年   5篇
  1999年   3篇
  1998年   5篇
  1997年   1篇
  1996年   2篇
  1995年   1篇
  1994年   3篇
  1993年   2篇
  1992年   2篇
  1991年   4篇
  1990年   10篇
  1989年   3篇
  1988年   1篇
  1987年   4篇
  1986年   1篇
  1985年   1篇
  1984年   2篇
  1983年   1篇
  1982年   1篇
  1981年   3篇
  1980年   3篇
  1964年   1篇
排序方式: 共有770条查询结果,搜索用时 0 毫秒
761.

BACKGROUND:

Although non-thyroidal illness syndrome (NTIS) is considered a negative prognostic factor, the alterations in free triiodothyronine (fT3) levels in trauma patients requiring massive transfusion have not been reported.

METHODS:

A prospective observational study comparing 2 groups of trauma patients was conducted. Group M comprised trauma patients requiring massive transfusions (>10 units of packed red blood cells) within 24 hours of emergency admission. Group C comprised patients with an injury severity score >9 but not requiring massive transfusions. Levels of fT3, free thyroxine (fT4), and thyroid-stimulating hormone (TSH) were evaluated on admission and on days 1, 2, and 7 after admission. The clinical backgrounds and variables measured including total transfusion amounts were compared and the inter-group prognosis was evaluated. Results are presented as mean±standard deviation.

RESULTS:

Nineteen patients were enrolled in each group. In both groups, 32 were men, and the mean age was 50±24 years. In group C one patient died from respiratory failure. The initial fT3 levels in group M (1.95±0.37 pg/mL) were significantly lower than those in group C (2.49±0.72 pg/mL; P<0.01) and remained low until 1 week after admission. Initial inter-group fT4 and TSH levels were not significantly different. TSH levels at 1 week (1.99±1.64 µIU/mL) were higher than at admission (1.48±0.5 µIU/mL) in group C (P<0.05).

CONCLUSION:

Typical NTIS was observed in trauma patients requiring massive transfusions. When initial resuscitation achieved circulatory stabilization, prognosis was not strongly associated with NTIS.KEY WORDS: Non-thyroidal illness syndrome, Massive transfusion, Trauma, Free triiodothyronine, Thyroid hormone  相似文献   
762.
Aim: The bioactive lipid, sphingosine-1-phosphate (S1P), has various roles in the physiology and pathophysiology of many diseases. There are five S1P receptors; however, the role of each S1P receptor in atherogenesis is still obscure. Here we investigated the contribution of S1P receptor 2 (S1P2) to atherogenesis by using a specific S1P2 antagonist, ONO-5430514, in apolipoprotein E-deficient ( Apoe −/− ) mice. Methods: Apoe −/− mice fed with a western-type diet (WTD) received ONO-5430514 (30 mg/kg/day) or vehicle. To examine the effect on atherogenesis, Sudan IV staining, histological analysis, qPCR, and vascular reactivity assay was performed. Human umbilical vein endothelial cells (HUVEC) were used for in vitro experiments. Results: WTD-fed Apoe −/− mice had significantly higher S1P2 expression in the aorta compared with wild-type mice. S1P2 antagonist treatment for 20 weeks reduced atherosclerotic lesion development ( p <0.05). S1P2 antagonist treatment for 8 weeks ameliorated endothelial dysfunction ( p <0.05) accompanied with significant reduction of lipid deposition, macrophage accumulation, and inflammatory molecule expression in the aorta compared with vehicle. S1P2 antagonist attenuated the phosphorylation of JNK in the abdominal aorta compared with vehicle ( p <0.05). In HUVEC, S1P promoted inflammatory molecule expression such as MCP-1 and VCAM-1 ( p <0.001), which was attenuated by S1P2 antagonist or a JNK inhibitor ( p <0.01). S1P2 antagonist also inhibited S1P-induced JNK phosphorylation in HUVEC ( p <0.05). Conclusions: Our results suggested that an S1P2 antagonist attenuates endothelial dysfunction and prevents atherogenesis. S1P2, which promotes inflammatory activation of endothelial cells, might be a therapeutic target for atherosclerosis.  相似文献   
763.
764.
OBJECTIVES: To investigate the feasibility and safety of the percutaneous dilatation of coronary septal collaterals and to allow its use as an access for retrograde approach to percutaneous coronary intervention (PCI) of coronary chronic total occlusions (CTOs). BACKGROUND: Despite improvements in percutaneous techniques and materials, CTO recanalization success rate is still suboptimal. The retrograde approach allows to significantly increase this success rate. However, its application via a bypass graft or epicardial collateral can potentially result in severe complications. A safer retrograde access is desired and would allow broadening the application of the retrograde approach in the percutaneous treatment of CTOs. METHODS: After a failed antegrade CTO recanalization attempt, a retrograde approach via septal collaterals was tried in 21 patients (19 males, 2 females). The septal collateral was accessed via the contralateral patent coronary artery and was crossed with a hydrophilic floppy wire. After successful wire crossing of the septal collateral, sequential low pressure dilatation was performed with a 1.25 or 1.5 mm balloon to allow the delivery of a balloon catheter up to the distal CTO site. RESULTS: Successful wire crossing and balloon dilatation of septal collaterals was achieved in 19 cases and in 17 cases, respectively. Postdilatation septal collateral diameter increased significantly reaching a mean diameter of 1.46 +/- 0.38 mm. Retrograde CTO recanalization was successfully performed in 71% of the cases. No major complications occurred. CONCLUSIONS: Coronary septal collaterals can be used as an access for the retrograde approach in the percutaneous treatment of CTOs.  相似文献   
765.
AIDS-related mortality remains a leading cause of preventable death among African-Americans. We sought to determine if community health workers could improve clinical outcomes among vulnerable African-Americans living with HIV in Miami, Florida. We recruited 91 medically indigent persons with HIV viral loads ≥1,000 and/or a CD4 cell count ≤350. Patients were randomized to a community health worker (CHW) intervention or control group. Viral load and CD4 cell count data were abstracted from electronic medical records. At 12 months, the mean VL in the intervention group was log 0.9 copies/μL lower than the control group. The CD4 counts were not significantly different among the groups. Compared to the control group, patients randomized to CHWs experienced statistically significant improvements in HIV viral load. Larger multi-site studies of longer duration are needed to determine whether CHWs should be incorporated into standard treatment models for vulnerable populations living with HIV.  相似文献   
766.

Objectives

The purpose of this study was to examine the treatment retention and efficacy of abatacept, the first member of a new class of biologic agents, in Japanese rheumatoid arthritis (RA) patients during clinical practice.

Methods

A retrospective multicenter study was conducted with patients who underwent abatacept therapy for 24 weeks (n = 143).

Results

Patients at baseline had a mean age of 63.5 years, a mean disease duration of 11.3 years, and a mean disease activity score in 28 joints (DAS28) of 4.5. Overall retention of abatacept treatment was 83.2 % at 24 weeks, when 46.2 % of patients achieved DAS28-defined low disease activity (LDA; DAS28 <3.2) and 26.6 % achieved DAS28-defined remission (DAS28 <2.6). LDA was achieved in a significantly higher proportion of patients without prior biologics therapy compared to those with prior biologics (60.9 vs. 34.2 %, p = 0.001). There was no significant difference between patients with or without concomitant methotrexate (MTX) therapy (45.2 vs. 47.5 %).

Conclusions

Abatacept therapy appears to be highly effective and well tolerated during clinical treatment of RA. Abatacept was particularly effective in patients with no history of biologics use, and did not appear to be dependent on concomitant MTX therapy.  相似文献   
767.

Background

This study sought to evaluate the prevalence of coronary artery disease (CAD) and the impact of epicardial fat volume (EFV) on CAD in symptomatic patients with a zero calcium score (CS) using multislice computed tomography (MSCT).

Methods

In this study, 1308 consecutive symptomatic patients who underwent 64-slice MSCT with a zero CS were evaluated. EFV was quantified with CS data sets. Presence of an obstructive plaque (diameter stenosis > 50%) and a CT-derived vulnerable plaque, which was defined as a plaque with remodeling index > 1.10 and mean CT density value < 30 HU, was assessed with a CT coronary angiography.

Results

Obstructive plaques were detected in 86 patients (7%) and CT-derived vulnerable plaques in 63 (5%). EFV was larger in patients with obstructive plaques than no plaque (124.3 ± 43.2 cm3 vs. 95.1 ± 40.3 cm3; p < 0.01). Patients with CT-derived vulnerable plaques had a greater amount of EFV than no plaque (133.0 ± 40.2 cm3 vs. 95.1 ± 40.3 cm3; p < 0.01). Multivariate analysis revealed EFV as a predictor of the presence of an obstructive and a CT-derived vulnerable plaque (per 10 cm3; Odds ratio (OR) 1.10; 95% confidence interval (CI), 1.04-1.16; p < 0.01 and OR 1.19; 95% CI, 1.12-1.27; p < 0.01). The combination of EFV and Framingham risk score (FRS) resulted in an area under the receiver-operating characteristic curve for prediction of obstructive and CT-derived vulnerable plaque of 0.75 and 0.75, which was significantly higher than 0.68 and 0.64 for FRS alone (p = 0.02 and p < 0.01).

Conclusions

A zero CS doesn't exclude CAD and EFV can be a useful marker of CAD in symptomatic zero CS patients.  相似文献   
768.
Three noncontrast‐enhanced MR venography techniques are presented for assessing deep vein thrombosis (DVT) at 0.5T in patients with metallic implants. Two cardiac‐gated 3D half‐Fourier FSE fresh blood imaging sequences with flow‐refocusing pulses (FR‐FBI) in the read‐out (RO) direction and without FR pulses (non‐FR‐FBI) were developed for slower‐flowing blood. For faster flowing blood, a swap phase‐encode arterial double‐subtraction elimination (SPADE) technique was developed. The three techniques were assessed both quantitatively using signal‐to‐noise (SNR) and contrast‐noise‐ratio (CNR) measurements and qualitatively by subjective image analysis in 15 volunteers. SPADE was compared to FR‐FBI in the pelvic veins and FR‐FBI was compared to non‐FR‐FBI in the thigh and calf veins. Both SPADE and FR‐FBI techniques produced significantly higher SNRs, CNRs, and image quality in each comparative study (P < 0.001). Five patients with metallic implants and confirmed DVT underwent SPADE (pelvic veins) and FR‐FBI (thigh and calf veins) examinations and the results were compared to conventional venography. The SPADE and FR‐FBI images showed all DVTs from all five patients without interference from implant susceptibility artifacts. The excellent image quality produced by both SPADE and FR‐FBI throughout peripheral vasculature demonstrates their promise for detecting DVT in postsurgery patients. Magn Reson Med, 2009. © 2009 Wiley‐Liss, Inc.  相似文献   
769.
Background and Aim:  Sinusoidal obstruction syndrome (SOS) is drug-induced liver injury that occurs in patients who receive hematopoietic cell transplantation and oxaliplatin-contained chemotherapy. The aim of study was to investigate the pharmacological treatment of SOS using a traditional Japanese medicine, Dai-kenchu-to (DKT).
Methods:  Male Sprague-Dawley rats were treated with monocrotaline (MCT) to induce SOS. The rats were divided into three groups: control, MCT and MCT+DKT groups. In the MCT+DKT group, DKT was gavaged at 12 h after MCT treatment and given every 12 h until the end of the protocol. The rats of MCT group were treated with water instead of DKT. At 48 h after MCT treatment, blood and liver samples were collected.
Results:  In the MCT+DKT group, the macroscopic and histological findings revealed liver congestion, sinusoidal alteration and the destruction of sinusoidal lining, which were comparable with those of the MCT group. However, the area of hepatic necrosis and serum AST levels significantly decreased in the MCT+DKT group compared with those of the MCT group. Treatment with DKT resulted in the reduction of neutrophil accumulation, myeloperoxidase activity and the expression of cytokine-induced neutrophil chemoattractant (CINC) and intracellular adhesion molecule-1 (ICAM-1) mRNA in the liver compared with those of the MCT group. Treatment with processed ginger, one of the ingredients in DKT, resulted in similar effects to those shown by DKT.
Conclusions:  Dai-kenchu-to attenuates MCT-induced liver injury by preventing neutrophil-induced liver injury through blockage of upregulation of CINC and ICAM-1 mRNA level.  相似文献   
770.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号